Liposome plasmid DNA complexes (lipoplexes) 
INTRODUCTION
Delivery and expression of transgenes using nonviral vector systems can be useful for gene transfer in a variety of settings both in vitro and in vivo. However, gene delivery using these methods is relatively inefficient and is impeded by the lack of specific mechanisms for cell entry, escape from liposomes and gene delivery to the nucleus (17) . Complexes of lipids and plasmid DNA require very high plasmid copy numbers per cell for effective transduction, the likely result of plasmid DNA entrapment and DNA degradation in lysosomes following lipoplex entry (5) . Viral vectors have proven more effective largely because they contain highly evolved mechanisms for receptor-mediated virus entry, escape from lysosomal degradation of the viral genome and viral functions, which rapidly deliver the viral genome to the nucleus. For this reason, a number of laboratories have attempted to incorporate viral proteins into lipoplexes to improve gene transfer, and indeed, whole virus particles have proven effective in this regard (1, 2, 9, 12, 15) . As examples, adenovirus and the hemagglutinating virus of Japan (HVJ) have been demonstrated to form complexes with DNA and used as a means of avoiding plasmid degradation in endosomes (1, 2, 9, 11) . In the former example, adenovirus/liposome-DNA complexes are taken into cells by the process of receptor-mediated endocytosis with the subsequent disruption of the endosomes by the virus coat proteins that co-release the plasmid DNA (11) . In the latter, the HVJ/lipoplex combination enters cells through the fusogenic mechanism of the virus envelope and does not enter endosomes (8) .
Herpes simplex virus (HSV) enters cells by virus envelope fusion with the cell surface membrane (16) and thus may also have the ability to mediate lipoplex entry into cells. Because HSV is a highly efficient virus having a broad host range and mutant viruses are available that do not kill the transduced cell (10, 13, 14) , we investigated the potential ability of defective HSV particles to improve liposome entry. The results of this investigation demonstrated that HSV greatly enhanced lipoplex gene transduction for a variety of cell types including those that were highly resistent to lipoplex-mediated transduction.
MATERIALS AND METHODS

Cell Culture
TSA cells are derived from a mammary adenocarcinoma, provided by Dr. Guido Forni (University of Bologna). The ICP4-complementing E5 cell line (kindly provided by Dr. Neal DeLuca, University of Pittsburgh) was used to propagate HSV virus deleted for ICP4. The cell lines 293, A549 and HeLa were obtained from ATCC (Manassas, VA, USA). All cells were grown in DMEM-10% fetal bovine serum, supplemented with 200 IU/mL penicillin and 50 mg/mL streptomycin (Life Technologies, Rockville, MD, USA).
Plasmids
The reporter construct used in these experiments was pHCMV-β -galactosidase (pHCMV-β -gal). This 7-kb plasmid was constructed by ligating a pHCMV-β -gal poly(A) cassette into pPUR (Clontech Laboratories, Palo Alto, CA, USA). Plasmid purification was achieved using the QIAfilter ™ maxi kit. (Qiagen, Valencia, CA, USA).
Virus
A herpes simplex replication defective mutant (d120), deleted for both copies of the ICP4 gene (3), was kindly provided by Dr. Neal DeLuca (University of Pittsburgh). This virus was O PTI P REP ™ (Nycomed Pharma AS, Oslo, Norway) gradient purified before use in transfection experiments (10) .
Preparation of Transfection Complexes
For transfecting 1 ×10 5 cells, 0.25 µ g DNA was mixed with 0.5 µ L Fu -GENE ™ 6 (Roche Molecular Biochemicals, Indianapolis, IN, USA) lipid in 100 µ L serum-free medium. After 20 min incubation at room temperature, virus was added to the complex, mixed briefly and the complexes added to cell monolayers cultured in 12-well plates (Becton Dickinson, Franklin Lakes, NJ, USA) in 0.5 mL complete medium. At 24 h after transfection, the cell monolayers were tested for β -gal activity using the o-nitrophenyl-β -D -galactopyranoside (ONPG) reporter gene assay (4). The cell protein concentration was determined by the BCA assay (Pierce Chemical, Rockford, IL, USA). All experiments were performed at least three times, and the results were plotted as the nanogram β -gal expressed per microgram cellular protein.
Glycine Treatment
Cells were infected with d120 virus for 2 h at 37ºC. The cultures were subsequently washed twice with PBS, pH 7.4, treated with ice-cold 0.5 M glycine, pH 3.0, for 1 min and again washed twice with PBS before the addition of complete medium to inactivate nonpenetrating virus (6) . At 24 h after transfection, the cell monolayers were tested for β -gal activity by ONPG assay (4) with the cell protein concentration determined by the BCA assay as described above.
Antibody Pretreatment
Serial dilutions of complement-independent, HSV-neutralizing monoclonal antibodies directed against HSV-1 glycoproteins B (gB) and D (gD) or mouse nonspecific control antibody (mouse IgG) were administered to cells immediately before infection (6, 7) . At 24 h after transfection, the cell monolayers were tested for β -gal activity using the ONPG assay (4) , and the total cell protein concentration was determined by the BCA assay.
RESULTS
HSV Enhancement of LipoplexMediated Transgene Expression
In order to determine whether HSV infection enhanced transfection, HSV was added to lipoplexes at various doses, and the mixtures were tested for efficiency of transduction of different cell types in culture. The results showed a linear correlation between virus dose and the level of β -gal expression in tests using TSA cells (Figure 1 ). Moreover, HSV enhancement was not affected by the presence of 10% serum in the transduction mixture, in contrast to results using adenovirus and HVJ for improving plasmid DNA transfection (2, 9) .
HSV also enhanced transfection in HeLa, 293 and A549 cells. In the presence of virus, β -gal expression increased from 25 ng/ µ g to 100 ng/ µ g in 293 cells and from approximately 10 ng/ µ g to 80 ng/ µ g in HeLa cells ( Figure  2A ). In TSA and A549 cells, transfection was virtually absent unless carried out in the presence of virus ( Figure  2B ). The number of β -gal-expressing cells that we observed varied for each cell type tested. For TSA cells, 0%-1% of the cells expressed the transgene, whereas this increased tenfold (10%-20%) following the addition of virus to the lipoplex ( Figure 2C) . For A549 cells, we observed a similar pattern in which between 0% and 1% of the cells expressed the transgene with lipoplex alone, while the addition of HSV to the complex resulted in β -gal expression in 10%-15% of the cells (Table 1) added to the lipoplex complex (Table  1) . Expression persisted for approximately four days after transfection with maximal expression at 24-48 h (data not shown). This transfection system was also not unduly toxic because the great majority of cells actively divided following the transfection procedure. Total cell protein assays were performed to assess the relative toxicity of the transfection system following the addition of virus to the lipoplex complex. As with the transfection efficiency, toxicity varied per cell type. For TSA cells, the protein yield was 80% of the untreated control (Table 2) . For 293 cells, it was 48%, and for A549 and HeLa cells, the yield was approximately 70% when virus was included in the complex (Table 2) . We had previously shown some cytotoxicity associated with the first-generation replication defective vector (10) .
HSV Enhancement of Transfection Is Most Effective if Virus Is Added to the Complex after Lipoplex Formation
Experiments were performed to determine whether the order of mixing lipid, plasmid and virus affected the efficiency of gene transfer and transgene expression. The effect of HSV enhancement was optimized if the lipid was incubated with the plasmid for 20 min before virus addition (Figure 3) . In contrast, any other order of mixing of these components, as well as simultaneous addition of components, was less effective. These results indicated that lipoplex formation was necessary before virus can effectively enhance transfection of the lipoplex complex. 
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Lipoplex-Mediated Transfection Required Viral Entry
To show that the process of HSV infection enabled more efficient transfection of lipoplexes, TSA cells were pretreated with complement-independent, virus-neutralizing antibodies specific for gD and gB before the addition of lipoplexes containing HSV (6, 7) . Cells that were pretreated with these antibodies were not transducible (Figure 4) , indicating that HSV infection was essential for transduction.
This conclusion was further supported by a treatment that destroys viruses attached to cells before entry (6) . In this experiment, HeLa cells were infected for 2 h at 37ºC and then treated with 0.5 M glycine, pH 3.0, buffer. Cells infected before transfection expressed higher levels of β -gal compared with infected cells treated with low-pH glycine buffer ( Figure 5 ). This result indicated that virions on the cell surfaces assist lipoplex entry using a pathway that improves gene transfer and expression.
DISCUSSION
This paper reports the first use of HSV to enhance cationic lipid-DNA transfection. HSV should be advantageous for this purpose because the efficiency of virus infection is very high, requiring only a single particle to infect a cell and initiate the replication cycle. Our studies indicate that HSV infection is required for transduction enhancement and implies that plasmid DNA is more effectively taken up into the cytoplasm as a consequence of virus particle entry. The role of the virus in this process was demonstrated further using neutralizing antibodies to block virus attachment and penetration, resulting in a corresponding decrease in transfection efficiency. Ultimately, increased transfection efficiency should reduce the plasmid DNA copy number needed to gain entry into the cell. As a consequence, in vivo applications may be more effective, both reducing cytotoxicity and inflammation because of the amount of lipid and DNA in the complex required for achieving adequate levels of transduction. Unlike other viral lipid DNA gene transfer systems, this method is serum resistant, suggesting that HSV-enhanced transduction may also be more effective when used in the host compared with other enhancing viruses. In these studies, we used a firstgeneration HSV vector deleted for the ICP4 immediate early (IE) gene (3). These vector preparations may contain 20-50-fold defective particles that could contribute to the enhanced transduction levels seen. However, they do not seem to dramatically affect the limited cytotoxicity associated with the vector. Together, our findings suggest that the use of replication defective herpes viruses engineered to preserve the integrity of host cell metabolism may provide a safe and improved lipoplex vector. We have recently engineered highly defective HSV genomic vectors deleted for multiple IE gene functions that fail to initiate lytic viral replication and display dramatically reduced toxicity in a variety of cell types (10) . These new vectors may prove ideal for use with the liploplex transfection system to increase transduction efficiency with limited cytotoxicity.
INTRODUCTION
Internal ribosome entry sites (IRESs) are short DNA sequences that initiate internal translation of RNA. The first IRES element was found in picornavirus RNAs, and subsequently many more were identified in other viruses as well as in eukaryotic organisms (4, 9) . The exact mechanism of this non-cap-dependent initiation remains unclear, though there is evidence that interaction between cis -elements and
